Monopar Therapeutics Stock Forecast

Buy or Hold candidate since Jun 12, 2026 Gain 72.88%

The Monopar Therapeutics Inc. stock price fell by -3.07% on the last day (Monday, 13th Jul 2026) from $106.60 to $103.33. During the last trading day the stock fluctuated 6.96% from a day low at $100.51 to a day high of $107.50. The price has risen in 6 of the last 10 days and is up by 17.85% over the past 2 weeks. Volume has increased on the last day by 65 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 214 thousand shares were bought and sold for approximately $22.15 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $107.32 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 69.05% during the next 3 months and, with a 90% probability hold a price between $124.13 and $181.43 at the end of this 3-month period.

MNPR Signals & Forecast

The Monopar Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $100.55 and $75.53. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, July 10, 2026, and so far it has fallen -3.07%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Monopar Therapeutics Inc. stock

Monopar Therapeutics Inc. finds support from accumulated volume at $99.27 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $7.00 between high and low, or 6.96%. For the last week, the stock has had daily average volatility of 9.79%.

The Monopar Therapeutics Inc. stock is overbought on RSI14 and the RSI has been falling for the last couple of days. This together with the fact that the stock is in the upper part of the trend poses a possible good selling opportunity for the short-term trader. However, one should note that some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $99.71 (-3.51%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 83 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (MNPR) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Monopar Therapeutics Inc. to open at $103.78, and during the day (based on 14 day Average True Range), to move between $99.94 and $106.72, which gives a possible trading interval of +/-$6.77 (+/-6.78%) up or down from last closing price. If Monopar Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 6.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $104.50 (1.13%) than the support at $99.27 (3.93%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Monopar Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Monopar Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.847 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $103.78 ( 0.434%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk